GVS
870976
Hangzhou CNCR-IT
300250
Shanghai Newtouch Software
688590
Ucap Cloud Information Technology Co.,Ltd
688228
Yangtze Optical Electronic
688143
CN Stock MarketDetailed Quotes
300146 Byhealth Co.,Ltd
- 11.36
- +0.02+0.18%
Market Closed Jan 24 15:00 CST
19.32BMarket Cap27.05P/E (TTM)
11.43High11.30Low93.36KlotVolume11.35Open11.34Pre Close106.13MTurnover0.83%Turnover Ratio11.06P/E (Static)1.70BShares17.7752wk High1.71P/B12.84BFloat Cap10.6552wk Low13.61Limit Up1.13BShs Float36.13Historical High9.07Limit Down1.15%Amplitude-1.15Historical Low0.90Dividend TTM11.37Avg Price47.82KlotAsk7.92%Div YieldTTM100Lot Size43.37KlotBid
Byhealth Co.,Ltd News
Express News | By-health Co., Ltd.: Net profit for 2024 is expected to decline by 55.33% to 68.51% year-on-year.
Tomson Beijian: 2024 Annual Results Forecast
The ten worst-performing consumer leaders of 2024.
Survival is the fundamental principle.
The review results of the 2024 By-health Co., Ltd. Scientific Nutrition Research Fund have been announced, and 6 projects have received funding.
Guangzhou, December 27, 2024 /PR Newswire/ -- On December 27, By-health Co., Ltd. announced the list of funding projects for the 2024 Scientific Nutrition Research Fund. After evaluation, a total of 6 projects will receive funding from the Fund, covering research directions such as nutrition and anti-aging, new material research and development, dried blood spot metabolomics detection technology, and the screening of natural functional ingredients. The Scientific Nutrition Research Fund is the successor to the By-health Research Fund, established in 2012, aimed at gathering scientific research strength and promoting fundamental and applied research centered on dietary nutritional supplements. To make the fund more inclusive and diverse.
By-health Co., Ltd. (300146.SZ): The company currently has no pet nutrition business.
On December 11th, Gelonghui reported that By-health Co., Ltd. (300146.SZ) stated on the investor interaction platform that the company currently has no pet nutrition business.
By-health Co., Ltd. (300146.SZ): The company has laid out a cross-border e-commerce business through brands like lifespace and BYHEALTH.
On December 4th, Glonghui reported that by-health co., ltd. (300146.SZ) stated on the investor interaction platform that the company is deploying cross-border e-commerce business through brands like lifespace and BYHEALTH.
Express News | Abu Dhabi National Energy Company and Abu Dhabi National Oil Company have received unconditional approval from the State Administration for Market Regulation for the establishment of a new joint venture.
By-Health Co., Ltd. (300146.SZ): has established traditional medicine store and pharmacy channels in several countries in Southeast Asia, as well as cross-border and local e-commerce channels. Currently, the scale is still relatively small.
Grace Bond on November 7th | By-Health Co., Ltd. (300146.SZ) accepted a specific survey on November 6, 2024, on the "company's overseas business layout". The company stated that the current overseas layout is mainly based on the lifespace brand, and has set up traditional pharmacies and beauty channels in several countries in Southeast Asia, as well as cross-border and local e-commerce channels, with the current scale still relatively small.
By-Health Co., Ltd. (300146.SZ): Currently, the inventory levels of the two major core product channels have been controlled within a reasonable range.
Gelonghui November 7th | by-health co., ltd. (300146.SZ) accepted a specific object investigation on November 6, 2024, regarding the progress of the switch of "two core products" and the inventory situation in channels. The company stated that the transition between old and new products has significantly impacted the company's third-quarter performance and is expected to be completed within this year. Currently, the inventory level of the two core products in the channels has been kept within a reasonable range.
Major MSCI adjustment! Brokerage stocks are most favored, 20 companies are being removed.
On November 7th, Beijing time, the international index compiler MSCI announced the results of the November stock index review. Among them, 4 Chinese stocks were newly included in the MSCI China Index, while 20 individual stocks were removed. All changes will take effect after the market closes on November 25, 2024.
Express News | MSCI China Index flagship adjustment: Favoring brokerages, removing stocks such as Anhui Kouzi Distillery.
By-Health Co., Ltd. (300146.SZ): This buyback has not yet been implemented.
Gelonghui November 1st | By-Health Co., Ltd. (300146.SZ) announced that, as of October 31, 2024, the company has not yet implemented this repurchase.
By-Health Co., Ltd. (300146): The adjustment of individual products is nearing completion, and the effects of reform are expected to be realized.
Event: The company released the 2024Q3 quarterly report, with the company's revenue for the first three quarters at 5.734 billion yuan, yoy-26.33%; net income attributable to the parent company at 0.869 billion yuan, yoy-54.31%; non-net profit attributable to the parent company at 8.07 billion yuan.
Express News | 11 listed companies' stocks have been repurchased, with dongguan aohai technology having the highest repurchase amount.
Facing challenges with performance under pressure in the first three quarters, by-health co., ltd. actively responded with proactive transformation.
Guangzhou, October 29, 2024 /PRNewswire/ -- Since the beginning of this year, the VDS industry's consumer environment has been continuously changing. Influenced by multiple factors such as intensified market competition and operational adjustments by companies, the industry leader by-health co., ltd. (300146.SZ) has been under performance pressure. In the first three quarters of this year, by-health co., ltd. achieved revenue of 5.734 billion yuan and net income attributable to the parent company of 0.869 billion yuan, both decreasing compared to the same period last year. Regarding offline channels, according to data from CMH, from January to August this year, nationwide retail pharmacy VDS sales fell by 20% year-on-year, with by-health co., ltd. experiencing a significant impact. As for online channels
Huachuang Securities Downgrades Byhealth to Neutral From Add; Price Target Is 13.50 Yuan
Express News | Huachuang Securities: Downgraded the rating of By-Health Co., Ltd. to Neutral.
By-Health Co., Ltd. (300146): Q3 performance under pressure, recommended to pay attention to adjustment progress.
Event: By-Health Co., Ltd. released the third quarter report of 2024, achieving revenue of 5.73 billion yuan in the first three quarters of 24, a year-on-year decrease of -26.3%; net profit attributable to the parent company was 0.87 billion yuan, a year-on-year decrease of -54.3%; non-recurring net profit attributable to the parent company 8.
By-Health Co., Ltd. (300146): Intensified competition, digesting inventory, short-term performance under pressure
Event: The company released the third quarter report of 2024, achieving a revenue of 5.73 billion yuan in the first three quarters, a year-on-year decrease of -26.3%; achieving a net income attributable to the parent company of 0.87 billion yuan, a year-on-year decrease of -54.3%; achieving a net income attributable to the parent company after deducting non-recurring items of 0.81 billion yuan,
Tomson Beijian: Report for the third quarter of 2024
